Seminars in Thrombosis and Hemostasis 1998: Vol 24 Table of Contents

3 Pages·1998·0.95 MB·English

SEMINARS IN THROMBOSIS AND HEMOSTASIS—VOL. 24, NO. 6, 1998
Number 1 Comparative In Vitro Investigation of Prothrombin Complex Con-
DISSEMINATED INTRAVASCULAR COAGULATION centrates, Jiirgen R6misch, Ph.D., Klaus Bonik, Ph.D., and Heinz-
SYNDROMES: POTENTIAL MANAGEMENT WITH Georg Miiller, Ph.D.
ANTITHROMBIN III CONCENTRATES Therapeutic Use of Antithrombin Concentrate in Sepsis, Robert
Hans-Peter Schuster, M.D. Balk, M.D., Thomas Emerson, Ph.D., Francois Fourrier, M.D.,
James A. Kruse, M.D., Eberhard F. Mammen, M.D., Hans-Peter
Preface Schuster, M.D., and Helmut Vinazzer, M.D.
Disseminated Intravascular Coagulation: Pathophysiological Mech- PFA-100™ System: A New Method for Assessment of Platelet Dys-
anisms and Manifestations, Rodger L. Bick, M.D., Ph.D., FACP function, Eberhard F. Mammen, M.D., Philip C. Comp, M.D.,
Antithrombin: Its Physiological Importance and Role in DIC, Ph.D., Robert Gosselin, Charles Greenberg, M.D., W. Keith Hoots,
Eberhard F. Mammen, M.D. M.D., Craig M. Kessler, M.D., Edward C. Larkin, M.D., Darla Liles,
The Anti-Inflammatory Properties of Antithrombin III: New Thera- M.D., and Diane J. Nugent, M.D.
peutic Implications, Kenji Okajima, M.D., Ph.D., and Mitsuhiro Announcements
Uchiba, M.D., Ph.D.
Derangements of Coagulation and Fibrinolysis in Critically Il
Patients with Sepsis and Septic Shock, Marc G. Vervloet, M.D., Number 3
Lambertus G. Thijs, M.D., Ph.D., and C. Erik Hack, M.D., Ph.D. THE INFLUENCE OF AGE ON HEMOSTASIS
Disseminated Intravascular Coagulation in Patients with Multiple AND THROMBOSIS
Organ Failure of Non-Septic Origin, John A. Penner, M.D. Shigenori Suzuki, M.D.
Treatment Options for Clinically Recognized Disseminated Intra-
vascular Coagulation, Matthias Riewald, M.D., and Hanno Riess, Preface
M.D. The Angiogenic Effect of Tissue Factor on Tumors and Wounds,
Antithrombin III in Animal Models of Sepsis and Organ Failure, Katsumi Nakagawa, M.D., Ph.D., Youming Zhang, Ph.D., Hajime
Gerhard Dickneite, Ph.D. Tsuji, M.D., Ph.D., Masami Yoshizumi, M.D., Teruhisa Kasahara,
Clinical Experience with Antithrombin III Concentrates in Criti- M.D., Hiromi Nishimura, M.D., Peter P. Nawroth, M.D., Ph.D., and
cally Ill Patients with Sepsis and Multiple Organ Failure, Bernd Masao Nakagawa, M.D., Ph.D.
Eisele, M.D., and Maurice Lamy, M.D. The Influence of 62-Glycoprotein I on Tissue Factor Activity,
Epilogue: Disseminated Intravascular Coagulation and Antithrom- Masahiro Ieko, M.D., Ph.D., Taro Yasukouchi, M.D., Ph.D., Ken-
bin III in Intensive Care Medicine: Pathophysiological Insights Ichi Sawada, M.D., Ph.D., and Takao Koike, M.D., Ph.D.
and Therapeutic Hopes, Hans-Peter Schuster, M.D. Anticoagulant Effects of Synthetic Retinoids and Activated Vita-
min D,, Takatoshi Koyama, M.D., and Shinsaku Hirosawa, M.D.
Treatment of Disseminated Intravascular Coagulation (DIC) with
Number 2 All-trans Retinoic Acid in an Endotoxin-Induced Rat Model,
SELECTED TOPICS IN HEMOSTASIS Keiji Aoshima, M.D., Hidesaku Asakura, M.D., Masahide Ya-
AND THROMBOSIS mazaki, M.D., Masanori Saito, M.D., Ichiro Kumabashiri, M.D.,
John W. Fenton II, Ph.D., F.A.C.B. Eriko Morishita, M.D., Yasuo Ontachi, M.D., Tomoe Mizutani,
M.D., Tsukasa Ichino, M.D., and Tamotsu Matsuda, M.D.
Preface Genetic Analysis of Mutations in Seven Japanese Families with
Thrombin and Antithrombotics, John W. Fenton II, Ph.D., F.A.C.B., Type I Antithrombin Deficiency, Tetsuo Ozawa, M.D., and Nobuo
Frederick A. Ofosu, Ph.D., Diane V. Brezniak, M.A., and Houria I. Sakuragawa, M.D., Ph.D.
Hassouna, M.D., Ph.D. Apoliprotein(a) and Thrombosis: Molecular and Genetic Bases of
Hemostasis and Malignancy, John L. Francis, Ph.D., John Bigger- Hyper-Lipoprotein(a)-emia, Akitada Ichinose, M.D., Ph.D., Koji
staff, Ph.D., and Ali Amirkhosravi, Ph.D. Suzuki, M.D., Ph.D., and Tetsuo Saito, M.D., Ph.D.
Laboratory Investigation of Hypercoagulability, John L. Francis, Genetic Polymorphisms and Risk of Coronary Artery Disease,
Ph.D. Mitsuru Murata, M.D., Koichi Kawano, M.D., Yumiko Matsubara,
Pharmacological Actions of Sulodexide, Frederick A. Ofosu, Ph.D. M.Sc., Kyozo Ishikawa, M.D., Kiyoaki Watanabe, M.D., and Yasuo
Is Coronary Artery Disease Initiated Perinatally?, Elizabeth A. Ikeda, M.D.
Leistikow, M.D., Ph.D. Significance of Membrane Glycoproteins in Platelet Interaction
The Role of Secondary Growth Factor Production in Thrombin- with Oxidized Low-Density Lipoprotein, Yukihiro Takahashi,
Induced Proliferation of Vascular Smooth Muscle Cells, George M.D., Hirotoshi Fuda, Ph.D., Hidekatsu Yanai, M.D., Harukuni
A. Stouffer, M.D., and Marschall S. Runge, M.D., Ph.D. Akita, M.D., Hui Shuping, M.D., Hitoshi Chiba, M.D., and Kazu-
Transcellular Signaling and Pharmacological Modulation of hiko Matsuno, M.D.
Thrombin-Induced Production of Plasminogen Activator In- Atherosclerosis: Coagulation and Fibrinolysis, Katsuo Sueishi,
hibitor-1 in Vascular Smooth Muscle Cells, Garry X. Shen, M.D., M.D.. Kojiro Ichikawa, M.D., Kazuhiko Kato, M.D., Kazunori
Ph.D., Song Ren, M.Sc., and John W. Fenton II, Ph.D., RA.C.B. Nakagawa, M.D., and Yong-Xiang Chen, M.D.
Research and Development Commitments in an Integrated Plasma Renal Expression of Fibrinolytic Genes and Tissue Factor in a
Collection and Plasma Fractionation Environment, Miryana Murine Model of Renal Disease as a Function of Age, Koji Ya-
Radosevich, Ph.D. mamoto, M.D., Ph.D., David J. Loskutoff, Ph.D., and Hidehiko
Use of the Electron Microscope for Diagnosis of Platelet Disorders, Saito, M.D.
James G. White, M.D. Analysis of Tissue-Type Plasminogen Activator Receptor (t-PAR)
Fibrinogen Structure and Fibrin Clot Assembly, Michael W. in Human Endothelial Cells, Hideharu Fukao, Ph.D., and Osamu
Mosesson, M.D. Matsuo, M.D., Ph.D.
SEMINARS IN THROMBOSIS AND HEMOSTASIS—VOL. 24, NO. 6, 1998
Differences Between Bone Marrow and Lung Endothelial Cells, Rational Diagnosis of Pulmonary Embolism (RADIA PE) in Symp-
Kiyotoshi Imai, M.D., and Masanobu Kobayashi, M.D. tomatic Outpatients with Suspected PE: An Improved Strategy
Multinucleated Variant Endothelial Cells (MVECs) in Human to Exclude or Diagnose Venous Thromboembolism by the Se-
Aorta: Chromosomal Aneuploidy and Elevated Uptake of LDL, quential Use of a Clinical Model, Rapid ELISA D-Dimer Test,
Osamu Tokunaga, M.D., Ph.D., Toshimi Satoh, M.D., Fumio Ya- Perfusion Lung Scan, Ultrasonography, Spiral CT, and Pul-
masaki, M.D., and Liging Wu, M.D. monary Angiography, Jan Jacques Michiels, M.D., Ph.D.
Analysis of Gene Expression in Homocysteine-Injured Vascular
Endothelial Cells: Demonstration of GRP78/BiP Expression,
Cloning and Characterization of a Novel Reducing Agent- Number 5
Tunicamycin Regulated Gene, Toshiyuki Miyata, Ph.D., Koichi THROMBOSIS AND THROMBOPHILIA
Kokame, Ph.D., Kishan L. Agarwala, Ph.D., and Hisao Kato, IN PERINATAL MEDICINE
Ph.D. Shigenori Suzuki, M.D.
Hemostatic Molecular Markers Before Onset of Disseminated In-
travascular Coagulation in Leukemic Patients, Hideo Wada, Preface
M.D., Nobuo Sakuragawa, M.D., Ph.D., and Hiroshi Shiku, M.D. Resistance to Activated Protein C in Women Using Orai Contra-
Erratum ceptives, Michael Spannagl, M.D., Andrea Dick, Anita Assmann,
Announcement Lothar Heinemann, M.D., Wolfgang Schramm, M.D.
Significance of the Plasminogen Activator Inhibitor of Placental
Type (PAI-2) in Pregnancy, Birger Astedt, M.D., Ph.D., Claes
Number 4 Lindoff, M.D., Ph.D., Ingegerd Lecander, Ph.D.
NEW DEVELOPMENTS IN DIAGNOSIS Management of Venous Thrombosis and Pulmonary Embolism af-
AND MANAGEMENT OF VENOUS ter Gynecological Surgery, Tomoko Adachi, M.D., Ph.D., Masao
THROMOBEMBOLISM Nakabayashi, M.D., Ph.D., Yoshihiko Takeda, M.D., Ph.D.
Jan Jacques Michiels, M.D., Ph.D. Relevance of Markers of Hemostasis Activation in Obstetrics/
Gynecology and Pediatrics, Francesco Dati, Ph.D., Hermann
Preface Pelzer, Ph.D., Carola Wagner, Ph.D.
Laboratory Diagnosis of Hereditary Thrombophilia, Jan Jacques Platelet Hemostatic Capacity (PHC) and Fibrinolytic Inhibitors
Michiels, M.D., Ph.D., and Karly Hamulyak, M.D., Ph.D. during Pregnancy, Shigenori Suzuki, M.D., and Setuko Morishita,
Screening Tests for Thrombophilic Patients: Which Tests, for Ph.D.
Which Patient, by Whom, When, and Why?, Philippe de Moer- Molecular Markers of the Endothelium, the Coagulation and the
loose, M.D., Henri Bounameaux, M.D., and Pier M. Mannucci, Fibrinolytic Systems in Healthy Newborns, Ralf Knéfler, M.D.,
M.D., Ph.D. Sigrun Hofmann, M.D., Gerhard Weissbach, M.D., Eberhard Kuh-
Molecular Biology and Pathophysiology of APC Resistance: lisch, Bernhard Neef, Ph.D., Martina Otte, M.D., Nils Pargac, M.D..,
Current Insights and Clinical Implications, Jan Rosing, Ph.D.., Gerald Nachtrodt, M.D.
H. Coenraad Hemker, Ph.D., and Guido Tans, Ph.D. Hypercoagulability and DIC in High-Risk Infants, Shigenori
The Anticoagulant Potential of the Protein C System in Hereditary Suzuki, M.D., Setsuko Morishita, Ph.D.
and Acquired Thrombophilia: Pathomechanisms and New Tools Diagnosis of DIC in Very Low Birth Weight Infants, Akira Shira-
for Assessing Its Clinical Relevance, Michae! Kraus, Ph.D. hata, M.D., Yoshitsugu Shirakawa, M.D., Chie Murakami, M.D.
A Protein C Pathway (PCP) Screening Test for the Detection of Anticoagulant Activity in Non-Immunoglobulin Fraction from
APC Resistance and Protein C or S Deficiencies, Fred J.L.M. Plasma of Patients with Antiphospholipid Syndrome (APS), Mo-
Haas, Ph.D., Barbara M. van Sterkenburg-Kamp, and Helraa A.M.M toi Sugimura, M.D., Ph.D., Fan Su, M.D., Naohiro Kanayma, M.D..,
Scheepers Hiroshi Kobayashi, M.D., Takao Kobayashi, M.D., Toshihiko Terao,
Factor V: Q%% Mutation—Resistance to Activated Protein C M.D.
(APC): Clinical Implications with Respect to Family Screening, Serological and Immunohistochemical Diagnosis of Amniotic Fluid
Saskia Middeldorp, M.D., and Jan van der Meer, M.D. Embolism, Hidekazu Oi, M.D., Hiroshi Kobayashi, M.D., Yasuyuki
Epidemiology of Factor V Leiden: Clinical Implications, Valerio de Hirashima, M.D., Tatsuya Yamazaki, M.D., Takao Kobayashi, M.D.,
Stefano, M.D., Patrizia Chiusolo, M.D., Katia Paciaroni, M.D., and Toshihiko Terao, M.D.
Giuseppe Leone, M.D. Hematopoietic Cytokine Levels and In Vitro Colony Formation
Hyperhomocysteinemia and Atherothrombotic Disease, Sylvia C. Assay in Fetal Anemia, Hideto Yamada, M.D., Emi H. Kato, M.D.,
de Jong, M.D., Michiel van den Berg, M.D., Ph.D., Jan A. Rauw- Itsuko Furuta, M.S., Nobuhiko Hoshi, Ph.D., Kazuki Koizumi,
erda, M.D., Ph.D., and Coen D.A. Stehouwer, M.D., Ph.D. M.D., Kenichi Sawada, M.D., Seiichiro Fujimoto, M.D.
Hyperhomocysteinemia and Venous Thrombosis, Gerard M.J. Bos, The Characteristics of Umbilical Cord Blood (UCB) and UCB
M.D., Ph.D., and Martin den Heijer, M.D., Ph.D. Transplantation, Masaharu Kasai, M.D., Ph.D., Nobuo Masauzi,
Rapid D-Dimer Assays to Exclude Deep Venous Thrombosis and M.D., Ph.D.
Pulmonary Embolism: Current Status and New Developments, A Clinicopathological Aspect of Chorionic Villous Hemorrhage
Mirian C.H. Janssen, M.D., Ph.D., Hub Wollersheim, M.D., Ph.D., Leading to Formation of Intervillous Thrombosis, Hiroaki Soma,
Bert Verbruggen, and Irena R.O. Novakova, M.D., Ph.D M.D., Yoshiaki Watanabe, M.D., Hiroyuki Osawa, M.D., Toshio
Kationa: Diagnosis of Deep Vein Thrombosis (RADIA DVT) in Hata, M.D.
Symptomatic Outpatients with Suspected DVT: Simplification
and Improvement of Decision Rule Analysis for the Exclusion
and Diagnosis of DVT by the Combined Use of a Simple Clinical Number 6
Model, a Rapid Sensitive D-Dimer Test, and Compression Ultra- PRIMARY HEMOSTASIS IN CHILDREN
sonography (CUS), Jan Jacques Michiels, M.D., Ph.D. Anton H. Sutor, M.D.
The Place of D-Dimer Testing in an Integrated Approach of Pa-
tients Suspected of Pulmonary Embolism, Philippe de Moerloose, Freface
M.D., Jan Jacques Michiels, M.D., Ph.D., and Henri Bounameaux, Editor’s Comments, Eberhard F. Mammen, M.D.
M.D. Platelet Function in the Newborn, Alan D. Michelson, M.D.
CUMULATIVE TABLE OF CONTENTS
Platelet Function Tests in Childhood. Measuring Aggregation and Supplement 1
Release Reaction in Whole Blood, Ralf Knéfler, M.D., Gerhard THROMBOPHILIA: A FORUM ON DIAGNOSIS
Weissbach, M.D., and Eberhard Kuhlisch AND MANAGEMENT IN OBSTETRICS, GYNECOLOGY,
Use of the PFA-100® in the Assessment of Primary, Platelet- AND SURGERY,
Related Hemostasis in a Pediatric Setting, Margaret L. Rand, Ronald A. Sacher, M.D.
Ph.D., Manuel D. Carcao, M.D., FRCP(C) and Victor S. Blanchette,
M.D., FRCP(C) Preface
The Bleeding Time in Pediatrics, Anton H. Sutor, M.D. Inherited Thrombophilic States, A. Koneti Rao, M.D., Robert
Acute Immune Thrombocytopenia in Childhood: Are We Treating Kaplan, M.D., and Sunita Sheth, M.D.
the Platelet Count?, Anton H. Sutor, M.D. Thrombophilia as a Multigenic Disorder, Joseph P. Miletich, M.D.,
Chronic Immune Thrombocytopenic Purpura in Childhood, Ph.D.
Thomas Kiihne, M.D. and Paul Imbach, M.D. Treatment and Prevention of Venous Thromboembolism, Russell
Desmopressin (DDAVP) in Bleeding Disorders of Childhood, Anton D. Hull, M.B.B.S., M.Sc., F.R.C.P.C., F.A.C.P., F.C.C.P., Graham F.
H. Sutor, M.D. Pineo, M.D., F.R.C.P.C., F.A.C.P., and Karen A. Valentine, M.D.,
The Rational Use of Platelet Transfusions in Children, Mary R. Ph.D., F.R.C.P.C.
Cahill, M.D., MRCP(UK), MRCPI, MRC Path and John S. Lilley- Women with Thrombophilia: Assessing the Risks for Thrombosis
man, D.Sc., FRCP, Frepath, FRCPCH with Oral Contraceptives or Hormone Replacement Therapy,
Coagulation Changes Associated with the Hemolytic Uremic Syn- Jamie K. Waselenko, M.D., Mary Catherine Nace, M.D., and
drome, Nadar Gordjan, M.D. and Anton H. Sutor, M.D. Barbara Alving, M.D.
Vascular Hemostasis in Flowing Blood in Children, Elizabeth M. Acquired Thrombophilia in Pregnancy, Penny Ballem, M.D.
Van Cott, M.D., and Eric F. Grabowski, M.D., Sc.D. Inherited Thrombophilia and Pregnancy: The Obstetric Perspec-
Antiphospholipid Antibodies in Children, Marilyn J. Manco- tive, John Bonnar, M.D., F.R.C.0.G., F.R.C.P.1., Richard Green,
Johnson, M.D. M.B., M.R.C.O.G., M.R.C.P.L., and Lucy Norris, B.A. (Mod), Ph.D.
Whole Blood Clot Lysis in Newborns and Adults after Adding Anticoagulant Treatment during Pregnancy: An Update, Donna
Different Concentrations of Recombinant Tissue-Plasminogen Dizon-Townson, M.D., and D. Ware Branch, M.D.
Activator (Rt-PA), Burkhard Trusen, M.D., Martin Riess, M.D., Should Surgical Patients Be Screened for Thrombophilia?, H.
Martin Zenbor, M.D., Manfred Rauh, Ph.D., Ernst Beinder, M.D., Brownell Wheeler, M.D.
Hermann Keuper, Ph.D., and Dieter Harms, M.D. Diagnosis and Management of Venous Thrombosis in the Surgical
Polymorphonuclear Elastase in Patients with Homozygous Type 1 Patient, Mark R. Jackson, M.D.
Plasminogen Deficiency and Conjunctivitis Lignosa, Anne-Marie Perioperative Management of Long-Term Anticoagulation, Clive
Mingers, M.D., Anton Philapitsch, Hans Peter Schwarz, M.D., Petra Kearon, M.B., M.R.C.P.(1), F.R.C.P.(C), Ph.D.
Zeitler, M.D., and Hans Wolfgang Kreth, M.D. Summary, Ronald A. Sacher, M.D.